These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 16052979
1. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features]. Kovács M, Nagy P, Pák G, Fehér J. Orv Hetil; 2005 Jun 26; 146(26):1375-81. PubMed ID: 16052979 [Abstract] [Full Text] [Related]
2. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases. Yamamoto H, Kojima A, Nagata S, Tomita Y, Takahashi S, Oda Y. Am J Surg Pathol; 2011 Sep 26; 35(9):1287-95. PubMed ID: 21836495 [Abstract] [Full Text] [Related]
3. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Miettinen M, Felisiak-Golabek A, Wang Z, Inaguma S, Lasota J. Am J Surg Pathol; 2017 May 26; 41(5):577-585. PubMed ID: 28288036 [Abstract] [Full Text] [Related]
4. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors. Kara T, Serinsoz E, Arpaci RB, Gubur O, Orekici G, Ata A, Colak T, Arican A. Pathol Res Pract; 2013 Jul 26; 209(7):413-7. PubMed ID: 23722018 [Abstract] [Full Text] [Related]
5. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers? Ríos-Moreno MJ, Jaramillo S, Pereira Gallardo S, Vallejo A, Mora M, García-Escudero A, Amérigo J, González-Cámpora R. Pathol Res Pract; 2012 Feb 15; 208(2):74-81. PubMed ID: 22197035 [Abstract] [Full Text] [Related]
6. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy]. Coindre JM, Emile JF, Monges G, Ranchère-Vince D, Scoazec JY. Ann Pathol; 2005 Oct 15; 25(5):358-85; quiz 357. PubMed ID: 16498290 [Abstract] [Full Text] [Related]
7. Diagnostic significance of DOG-1 and PKC-θ expression and c-Kit/PDGFRA mutations in gastrointestinal stromal tumours. Wang C, Jin MS, Zou YB, Gao JN, Li XB, Peng F, Wang HY, Wu ZD, Wang YP, Duan XM. Scand J Gastroenterol; 2013 Sep 15; 48(9):1055-65. PubMed ID: 23862765 [Abstract] [Full Text] [Related]
8. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. West RB, Corless CL, Chen X, Rubin BP, Subramanian S, Montgomery K, Zhu S, Ball CA, Nielsen TO, Patel R, Goldblum JR, Brown PO, Heinrich MC, van de Rijn M. Am J Pathol; 2004 Jul 15; 165(1):107-13. PubMed ID: 15215166 [Abstract] [Full Text] [Related]
9. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining. Lee HE, Kim MA, Lee HS, Lee BL, Kim WH. J Clin Pathol; 2008 Jun 15; 61(6):722-9. PubMed ID: 18381383 [Abstract] [Full Text] [Related]
10. High-risk CD117-positive gastrointestinal stromal tumor of the colon in a 12-year-old girl: adjuvant treatment with imatinib mesylate. Okur A, Oguz A, Karadeniz C, Pinarli FG, Ozen O, Ekinci O. Tumori; 2012 Jun 15; 98(2):59e-62e. PubMed ID: 22678007 [Abstract] [Full Text] [Related]
11. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Demetri GD. Semin Oncol; 2001 Oct 15; 28(5 Suppl 17):19-26. PubMed ID: 11740803 [Abstract] [Full Text] [Related]
12. [Therapeutic targets in gastrointestinal stromal tumors]. Wardelmann E, Schildhaus HU, Merkelbach-Bruse S, Büttner R. Verh Dtsch Ges Pathol; 2006 Oct 15; 90():73-9. PubMed ID: 17867582 [Abstract] [Full Text] [Related]
13. Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare events. Huss S, Pasternack H, Ihle MA, Merkelbach-Bruse S, Heitkötter B, Hartmann W, Trautmann M, Gevensleben H, Büttner R, Schildhaus HU, Wardelmann E. Hum Pathol; 2017 Apr 15; 62():206-214. PubMed ID: 28159677 [Abstract] [Full Text] [Related]
14. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors. González-Cámpora R, Delgado MD, Amate AH, Gallardo SP, León MS, Beltrán AL. Anal Quant Cytol Histol; 2011 Feb 15; 33(1):1-11. PubMed ID: 22125840 [Abstract] [Full Text] [Related]
15. DOG1 and PKC-θ are useful in the diagnosis of KIT-negative gastrointestinal stromal tumors. Kang GH, Srivastava A, Kim YE, Park HJ, Park CK, Sohn TS, Kim S, Kang DY, Kim KM. Mod Pathol; 2011 Jun 15; 24(6):866-75. PubMed ID: 21358619 [Abstract] [Full Text] [Related]
16. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. Liegl B, Hornick JL, Corless CL, Fletcher CD. Am J Surg Pathol; 2009 Mar 15; 33(3):437-46. PubMed ID: 19011564 [Abstract] [Full Text] [Related]
17. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Miettinen M, Wang ZF, Lasota J. Am J Surg Pathol; 2009 Sep 15; 33(9):1401-8. PubMed ID: 19606013 [Abstract] [Full Text] [Related]
18. Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang W. Histol Histopathol; 2004 Apr 15; 19(2):565-74. PubMed ID: 15024716 [Abstract] [Full Text] [Related]
19. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH, Nelson SD, Kim DH, Choi KU, Kim SJ, Min KW, Jang KS, Paik SS, Oh YH, Chae SW, Sohn JH, Kim HJ, Cho YK, Kim BI, Park DI, Sohn CI, Oh S, Choi SH, Choi YJ, Woo HY, Park YL, Park SJ, Lee SH, Ryu S, DO SI, Kang G, Kim K, Cho YH, Pyo JS. Anticancer Res; 2012 Mar 15; 32(3):923-37. PubMed ID: 22399613 [Abstract] [Full Text] [Related]